Ho-Youl Lee

Title: Ho-Youl Lee: Innovator in Pharmaceutical Compounds

Introduction

Ho-Youl Lee is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various diseases. With a total of 2 patents, his work focuses on innovative solutions for health-related issues.

Latest Patents

One of his latest patents is titled "Heterocyclic compound as a protein kinase inhibitor." This invention provides a novel compound that exhibits protein kinase inhibition activity. The compound, along with its stereoisomer or pharmaceutically acceptable salt, shows effectiveness in preventing or treating diseases related to protein kinase, such as cancer, autoimmune diseases, neurological disorders, and metabolic diseases. Another significant patent is "Use of aminoalkylbenzothiazepine derivatives." This disclosure relates to a pharmaceutical composition aimed at preventing or treating non-alcoholic fatty liver disease or dyslipidemia, utilizing an aminoalkylbenzothiazepine derivative or its pharmaceutically acceptable salt as an active ingredient.

Career Highlights

Ho-Youl Lee has worked with prominent companies in the pharmaceutical industry, including Hk Inno.n Corporation and CJ Healthcare Corporation. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Throughout his career, Ho-Youl Lee has collaborated with talented individuals such as So Young Ki and Hyuk Woo Lee. These collaborations have likely enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Ho-Youl Lee's contributions to pharmaceutical innovations demonstrate his commitment to addressing critical health challenges through his inventive work. His patents reflect a dedication to improving treatment options for various diseases, showcasing the impact of his research in the medical community.